North America Animal Antimicrobial And Antibiotics Market Size & Outlook
North America animal antimicrobial and antibiotics market, 2018-2030 (US$M)
Related Markets
North America animal antimicrobial and antibiotics market highlights
- The North America animal antimicrobial and antibiotics market generated a revenue of USD 142.5 million in 2022.
- The market is expected to grow at a CAGR of 3.6% from 2023 to 2030.
- In terms of segment, antibiotics was the largest revenue generating type in 2022.
- Antimicrobial is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 142.5 million |
| Market revenue in 2030 | USD 189.2 million |
| Growth rate | 3.6% (CAGR from 2022 to 2030) |
| Largest segment | Antibiotics |
| Fastest growing segment | Antimicrobial |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antimicrobial, Antibiotics |
| Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Elanco Animal Health Inc, Neogen Corp, Phibro Animal Health Corp Class A, Vetoquinol SA, Virbac SA, Zoetis Inc Class A |
Other key industry trends
- In terms of revenue, North America region accounted for 21.0% of the global animal antimicrobial and antibiotics market in 2022.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 270.2 million by 2030.
Antibiotics was the largest segment with a revenue share of 60.91% in 2022. Horizon Databook has segmented the North America animal antimicrobial and antibiotics market based on antimicrobial, antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
The animal antimicrobial and antibiotics market in North America is a significant segment of the animal healthcare industry. The market is expected to grow in the coming years due to factors such as increasing demand for animal-based food products, rising prevalence of animal diseases, and the need to increase the productivity of livestock.
There has been a trend towards reducing the use of antibiotics in animals in North America over the past several years. This is due to concerns about antibiotic resistance, which can occur when bacteria are exposed to antibiotics and evolve to become resistant to them. Overuse of antibiotics in animal agriculture can contribute to the development of antibioticresistant bacteria, which can be a threat to public health.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Animal Antimicrobial And Antibiotics Market Scope
Animal Antimicrobial And Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America animal antimicrobial and antibiotics market size, by country, 2018-2030 (US$M)
North America Animal Antimicrobial And Antibiotics Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
